CNSI Cambridge Neuroscience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CNSI Cambridge Neuroscience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (175)	6/24/1997 11:22:00 AM
From: TheSlowLane	of 675

CNSI stock price is collapsing... Whoooosh!!! The sound of my money going down the toilet. Anyone know why CNSI just lost half of its value? I can't get to my news feed, the server is too busy. Guess we didn't have to wait as long as we thought for "results". Never mind, here it is... Cambridge closes stroke trial enrollment June 24, 1997 08:23 AM CAMBRIDGE, Mass., June 24 (Reuter) - Cambridge NeuroScience Inc said Tuesday it has stopped taking new patients into its phase III trials of its stroke drug called of CERESTAT. The company said concerns were raised during an interim analysis of data over the benefit to risk ratio of drug treatment. Enrollment in the phase III trials of the drug in traumatic brain injury is continuing as planned. Cambridge, along with its partner in the study Boehringer Ingelheim, now plans to collect further information and conduct an expanded benefit to risk analysis on all of the about 600 patients enrolled in order to assess clinical improvement and safety. The international stroke trial, initiated in July 1996, was designed to examine the efficacy of CERESTAT. Data collection will continue for three months, and following verification will be analyzed for efficacy and safety. The independent Data Safety and Monitoring Board for the trial will review the analysis and make a recommendation regarding the continuation of the trial.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next